TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30807455

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 528

Group type: COMPARATOR
Intervention: Observational treatment
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: Both groups (Antibiotic and Observational)
Number of subjects: 528
Study: 29968187

Group type: EXPERIMENTAL
Intervention: Adequate vitamin D group (AVD; serum 25(OH)D > 50 nmol/l)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inadequate vitamin D group (IVD; serum 25(OH)D < 50 nmol/l)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: OAGB surgery
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D concentrations
Number of subjects: 50
Study: 26889974

Group type: EXPERIMENTAL
Intervention: Intermittent chemotherapy
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Continuous chemotherapy
Number of subjects: 1630
Study: 25153791

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 20 and 30 Hz
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 40 and 50 Hz
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonvibration (0 Hz)
Number of subjects: 40
Study: 22960817

Group type: EXPERIMENTAL
Intervention: Permethrin 5% cream as single application
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Topical ivermectin 1% lotion as single application
Number of subjects: 315

Group type: COMPARATOR
Intervention: Oral ivermectin 200 mcg/kg as single dose
Number of subjects: 315
Study: 20960535

Group type: EXPERIMENTAL
Intervention: Combination therapy with rosuvastatin (R) 5, 10, or 20 mg + fenofibric acid (FA) 135 mg
Number of subjects: 401

Group type: COMPARATOR
Intervention: Fenofibric acid (FA) monotherapy
Number of subjects: 401

Group type: COMPARATOR
Intervention: Rosuvastatin (R) monotherapy
Number of subjects: 401
Study: 17363756

Group type: EXPERIMENTAL
Intervention: Topiramate CR (175 mg/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 15712850

Group type: EXPERIMENTAL
Intervention: Coarse wheat bran (10-20 g/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low fibre placebo
Number of subjects: 28
Study: 12577231

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy with radiation and 5-fluorouracil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemcitabine as first-line treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies with gemcitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined-modality approaches with gemcitabine and radiation
Number of subjects: 0
Study: 11334066

Group type: EXPERIMENTAL
Intervention: Erythromycin (10 mg/kg IV)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Erythromycin (additional doses)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (additional doses)
Number of subjects: 74
Study: 9727545

Group type: EXPERIMENTAL
Intervention: Ticlopidine (500 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Ticlopidine and Aspirin)
Number of subjects: 20
Study: 8052456

Group type: EXPERIMENTAL
Intervention: Cranberry juice cocktail (300 mL daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 2660603

Group type: EXPERIMENTAL
Intervention: Primary care case management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Medicaid programs (comparison group)
Number of subjects: 0
Study: 1099915

Group type: EXPERIMENTAL
Intervention: Idoxuridine (IDU)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Adenine arabinoside (ara-A)
Number of subjects: 112
Study: 581856

Group type: EXPERIMENTAL
Intervention: Compression bandage with a plaster cylinder, weight-bearing allowed with crutches, discharged after four days in hospital.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional method of a compression bandage with a backsplint, followed by a 10-day stay in hospital.
Number of subjects: 80
Study: 31307654

Group type: EXPERIMENTAL
Intervention: RC-LE (reversed hanging protocol)
Number of subjects: 27

Group type: COMPARATOR
Intervention: LE-RC (commonly used hanging protocol)
Number of subjects: 27

Group type: COMPARATOR
Intervention: FFDM (Full-Field Digital Mammography)
Number of subjects: 27
Study: 29923298

Group type: EXPERIMENTAL
Intervention: iGlarLixi (fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lixisenatide alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study: 26907339

Group type: EXPERIMENTAL
Intervention: High Dairy Intake (HD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low Dairy Intake (LD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Energy-restricted intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet effect
Number of subjects: 0
Study: 24931923

Group type: EXPERIMENTAL
Intervention: Nasal prong oxygen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Anaesthesia machine flush oxygen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard pre-oxygenation with a simulated facemask leak
Number of subjects: 24
Study: 22725648

Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg bolus, followed by continuous infusion of 20 μg/kg/min after intubation)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IV flurbiprofen (1 mg/kg before skin incision)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IV parecoxib (40 mg before skin incision)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (sevoflurane only)
Number of subjects: 105
Study: 21165295

Group type: EXPERIMENTAL
Intervention: Lactobacillus (Lacidofil® cap)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 18056558

Group type: EXPERIMENTAL
Intervention: Buckwheat honey
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Honey-flavored dextromethorphan (DM)
Number of subjects: 105

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 105
Study: 16132930

Group type: EXPERIMENTAL
Intervention: Imatinib mesylate treatment
Number of subjects: 45
Study: 11834117

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise training with 3 sets at approximately 50% 1RM and 30 seconds interset rest, performed twice a week for 12 weeks.
Number of subjects: 10
Study: 10071990

Group type: EXPERIMENTAL
Intervention: Esmolol (continuous i.v. beta-blockade)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo plus usual medical therapy
Number of subjects: 26
Study: 7899948

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions (specific interventions not detailed)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Higher median family income
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Being disabled from working
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Distance from hospital (moderate)
Number of subjects: 325
Study: 1903319

Group type: EXPERIMENTAL
Intervention: Intravenous nutrition
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fasted group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: In vitro rates of protein synthesis with fed serum
Number of subjects: 18

Group type: COMPARATOR
Intervention: In vitro rates of protein synthesis with fasted serum
Number of subjects: 18
Study: 6781888

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 33

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 33
Study: 30813149

Group type: EXPERIMENTAL
Intervention: Glutamine (GLN) supplementation at a dose of 10g every 8 hours (prophylactic powdered GLN orally)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Glutamine (GLN) supplementation
Number of subjects: 60
Study: 31038033

Group type: EXPERIMENTAL
Intervention: Short sleep duration (5-6 hours)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 237

Group type: COMPARATOR
Intervention: Diet quality indices
Number of subjects: 237
Study: 26450442

Group type: EXPERIMENTAL
Intervention: Intensive therapy (robot-assisted therapy plus intensive conventional therapy)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 127
Study: 23957932

Group type: EXPERIMENTAL
Intervention: Relaxing music
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Neutral music
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Stressful music
Number of subjects: 93

Group type: COMPARATOR
Intervention: No music
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Pleasant music (regardless of type)
Number of subjects: 93
Study: 22428942

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 203

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 203
Study: 18353529

Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen velocity (PSAV)
Number of subjects: 2217

Group type: EXPERIMENTAL
Intervention: Use of PSAV cut-offs
Number of subjects: 2217
Study: 17957152

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (2.2 g DHA and 1.1 g EPA)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 98
Study: 15891550

Group type: EXPERIMENTAL
Intervention: Operative treatment (closed reduction and percutaneous pin fixation, open reduction and internal fixation, and arthrodesis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoperative treatment (elevation, ice, early mobilization, cyclic compression of the plantar arch)
Number of subjects: 0
Study: 11812816

Group type: EXPERIMENTAL
Intervention: Educational campaign
Number of subjects: 187

Group type: COMPARATOR
Intervention: Malathion spraying
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Combination of both treatments
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 187
Study: 9987151

Group type: EXPERIMENTAL
Intervention: Vaginal mucosal vaccine for UTI
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 7590584

Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 0
Study: 2279255

Group type: EXPERIMENTAL
Intervention: Ibopamine
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Ibopamine plus HCTZ
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 384815

Group type: EXPERIMENTAL
Intervention: Levamisole treatment
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 341
Study: 31278815

Group type: EXPERIMENTAL
Intervention: Moog Simodont dental trainer (VR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No exposure to VR (Control)
Number of subjects: 32
Study: 30440120

Group type: EXPERIMENTAL
Intervention: Non-invasive DNA examination
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Induced labor due to confirmed chromosome abnormality
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Group A (positive soft markers)
Number of subjects: 544

Group type: COMPARATOR
Intervention: Group B (no obvious abnormalities)
Number of subjects: 544
Study: 27769585

Group type: EXPERIMENTAL
Intervention: New regression formula for predicting postoperative ACD using ATA depth, preoperative ACD, and axial length (AL).
Number of subjects: 304

Group type: COMPARATOR
Intervention: Sanders‐Retzlaff‐Kraff theoretic (SRK/T) formula.
Number of subjects: 304

Group type: COMPARATOR
Intervention: Haigis formula.
Number of subjects: 304
Study: 25386795

Group type: EXPERIMENTAL
Intervention: Hypothetical diagnostic blood test
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Nodule size
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Smoking history
Number of subjects: 153
Study: 23227678

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Nimodipine
Number of subjects: 192
Study: 20212201

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones
Number of subjects: 9690

Group type: COMPARATOR
Intervention: Retinopathy severity
Number of subjects: 9690

Group type: COMPARATOR
Intervention: Age
Number of subjects: 9690

Group type: COMPARATOR
Intervention: Hemoglobin A(1c)
Number of subjects: 9690

Group type: COMPARATOR
Intervention: Duration of diabetes
Number of subjects: 9690

Group type: COMPARATOR
Intervention: Sex
Number of subjects: 9690

Group type: COMPARATOR
Intervention: Ethnicity
Number of subjects: 9690
Study: 18803532

Group type: EXPERIMENTAL
Intervention: 5-day course of oral prednisolone (1 mg/kg)
Number of subjects: 201

Group type: COMPARATOR
Intervention: 3-day course of prednisolone plus placebo for 2 days
Number of subjects: 201
Study: 16197587

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (100 microg for 6 weeks followed by 200 microg for a further 6 weeks)
Number of subjects: 23
Study: 12392333

Group type: EXPERIMENTAL
Intervention: Follow-up home visits by a physician
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Physiotherapist instruction in the patient's home
Number of subjects: 155

Group type: COMPARATOR
Intervention: Standard aftercare
Number of subjects: 155
Study: 10201583

Group type: EXPERIMENTAL
Intervention: Initial medications (n=307) with a stepped regimen to lower intraocular pressure
Number of subjects: 607

Group type: COMPARATOR
Intervention: Immediate filtration surgery (n=300) with trabeculectomy to lower intraocular pressure
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Initial medications (n=307)
Number of subjects: 607

Group type: COMPARATOR
Intervention: Immediate filtration surgery (n=300)
Number of subjects: 607
Study: 7776933

Group type: EXPERIMENTAL
Intervention: 2000 micrograms BDP plus 800 micrograms salbutamol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo plus 800 micrograms salbutamol
Number of subjects: 24
Study: 2149017

Group type: EXPERIMENTAL
Intervention: Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, 2.8 micrograms/kg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 95609

Group type: EXPERIMENTAL
Intervention: Amylase-creatinine clearance ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fraction of pancreatic isoamylase in serum
Number of subjects: 0
Study: 31126631

Group type: EXPERIMENTAL
Intervention: Doxycycline in combination with oral corticosteroids for 20 days
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo in combination with oral corticosteroids for 20 days
Number of subjects: 49
Study: 28347493

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (TVUS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional transabdominal ultrasound (TAUS)
Number of subjects: 120
Study: 25925807

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 212

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 212
Study: 23726870

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) treatment for depression
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Adjusted Hamilton Depression Rating Scale (HamD) score (omitting sleep items)
Number of subjects: 139
Study: 21781066

Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control
Number of subjects: 41
Study: 19346367

Group type: EXPERIMENTAL
Intervention: Placental malaria (PM)
Number of subjects: 1662

Group type: EXPERIMENTAL
Intervention: Adjustment for maternal plasma viral load and CD4+ cell count
Number of subjects: 1662

Group type: EXPERIMENTAL
Intervention: Low maternal plasma viral load
Number of subjects: 1662
Study: 16824994

Group type: EXPERIMENTAL
Intervention: Peak early diastolic strain rate (ESR)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Peak late diastolic strain rate
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Time from QRS to ESR
Number of subjects: 25

Group type: COMPARATOR
Intervention: Flow propagation velocity
Number of subjects: 25
Study: 12915334

Group type: COMPARATOR
Intervention: Eicosapentaenoic acid (EPA) supplementation, with a daily dose of up to 2.6 grams of fish oil (equivalent to about 1.6 grams of EPA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Reduction of dietary arachidonic acid
Number of subjects: 12
Study: 11910618

Group type: EXPERIMENTAL
Intervention: Prototype patch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Industrial counterpart patch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reservoir patch (Estraderm TTS 50)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference matrix patch (System 50)
Number of subjects: 20
Study: 9162737

Group type: EXPERIMENTAL
Intervention: CD34 positive (CD34+) spindle cells in hypertrophic scars and keloids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-inflammatory scars or non-inflammatory central portion of keloids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD34-proline‐4‐hydroxylase+ cells during inflammation subsiding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD34 expression in relation to type I collagen synthesis
Number of subjects: 0
Study: 7835364

Group type: EXPERIMENTAL
Intervention: Elevated anticardiolipin antibody (ACLA) titres (IgM and IgG)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Elevated anticardiolipin antibody (ACLA) titres (IgG)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Occurrence of anti-heart muscle antibodies (AHA) > or = 2+
Number of subjects: 57
Study: 3288468

Group type: EXPERIMENTAL
Intervention: Atenolol 50mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Nifedipine 20mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Combination of Atenolol and Nifedipine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control (individual components)
Number of subjects: 3
Study: 29580446

Group type: EXPERIMENTAL
Intervention: Chicago Urban Resiliency Building (CURB) intervention
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Clinic staff exit interviews
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Primary care providers and clinic staff surveys
Number of subjects: 28
Study: 26276915

Group type: EXPERIMENTAL
Intervention: Patients after SCA
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Patients with a history of myocardial infarction without SCA
Number of subjects: 91

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 91
Study: 23690410

Group type: EXPERIMENTAL
Intervention: CanChange intervention (11 theory‐based telephone‐delivered health coaching sessions over 6 months)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 410
Study: 19458956

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia (group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: General anaesthesia (group B)
Number of subjects: 80
Study: 18983380

Group type: EXPERIMENTAL
Intervention: Saline douching (3 times per day for 6 weeks)
Number of subjects: 23
Study: 16911315

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of half-isotonic saline (1 mL/kg/h) for 12 h before surgery (hydration group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fluid restriction (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of half-isotonic saline (hydration group)
Number of subjects: 45
Study: 12796167

Group type: EXPERIMENTAL
Intervention: Triple drug treatment (TDG) - albuterol, ipratropium bromide, and flunisolide
Number of subjects: 172

Group type: COMPARATOR
Intervention: A/IB (albuterol and ipratropium bromide)
Number of subjects: 172

Group type: COMPARATOR
Intervention: A/F (albuterol and flunisolide)
Number of subjects: 172
Study: 10968813

Group type: EXPERIMENTAL
Intervention: 250 mg hypericum extract ZE 117 twice daily for 6 weeks
Number of subjects: 324

Group type: COMPARATOR
Intervention: 75 mg imipramine twice daily for 6 weeks
Number of subjects: 324
Study: 8917818

Group type: EXPERIMENTAL
Intervention: Dots replotted in random positions in each new frame
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dots with a set displacement but following a random walk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dots moving in random directions which remain constant for a given dot
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Signal dots may either remain the same or be re-selected afresh on each frame
Number of subjects: 0
Study: 1767901

Group type: EXPERIMENTAL
Intervention: Rectal cisapride 30 mg and intramuscular morphine 10 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rectal cisapride 60 mg and intramuscular morphine 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo suppositories and intramuscular morphine 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo suppositories only
Number of subjects: 40
Study: 6805590

Group type: EXPERIMENTAL
Intervention: Drug treatment
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Muscle relaxation
Number of subjects: 37

Group type: COMPARATOR
Intervention: Biofeedback
Number of subjects: 37

Group type: COMPARATOR
Intervention: Salt restriction
Number of subjects: 37
Study: 31408478

Group type: EXPERIMENTAL
Intervention: Seroprevalence of VZV
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Self-reported history of VZV infection
Number of subjects: 1184
Study: 29066145

Group type: EXPERIMENTAL
Intervention: IV acetaminophen (4 doses of 1 g over 15 minutes every 6 hours for 24 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IV placebo (saline placebo, equal volume to acetaminophen)
Number of subjects: 0